FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website http://www.fitscreening.eu/patients

 

 

Press releases

Here´s your quick access to our latest press releases.

Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19 Sysmex Group Formulates New Long-Term Management Goals Sysmex Announces “Sysmex Eco-Vision 2025” Sysmex to Establish Bio-Diagnostic Reagent Center Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor Sysmex to Launch JICA Project in the Republic of Ghana: "Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology” Sysmex Europe GmbH to Transfer Management of All European Installations of The DigniCap Scalp Cooling System Back to Dignitana AB Sysmex Launches Caresphere™, a New Network Solution Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics” Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan OncoBEAM™ RAS CRC liquid biopsy test now reimbursed in Germany by BARMER Sysmex to Be Special Sponsor of the Kobe Marathon 2018 Sysmex Celebrates Its 50th Anniversary of Establishment A fondo: Comparación de los resultados obtenidos en los análisis de biopsias líquidas OncoBEAM RAS CRC e Idylla ctKRAS para la detección de la mutación KRAS presentados en la reunión GI de la ASCO en 2018 In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018 In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018 Comparación de los resultados obtenidos con OncoBEAM™ RAS CRC y el test Idylla ct KRAS presentados en la reunión ASCO GI 2018 Liquid Biopsy performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS testing presented at ASCO GI 2018 meeting

Press enquiries

About Sysmex

Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN
See the features
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
Explore our microsite
See our collection